According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is $0.97. In 2022 the company made an earnings per share (EPS) of $0.93 a decrease over its 2021 EPS that were of $1.38.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.94 | 1.41% |
2022 | $0.93 | -32.67% |
2021 | $1.38 | -16.9% |
2020 | $1.66 | 2.54% |
2019 | $1.62 | 19.37% |
2018 | $1.36 | 98.42% |
2017 | $0.69 | 41.84% |
2016 | $0.48 | 1227.12% |
2015 | $0.03640 | -117.81% |
2014 | -$0.20 | 184.25% |
2013 | -$0.07192 | -12.81% |
2012 | -$0.08249 | -433.93% |
2011 | $0.02470 | -126.14% |
2010 | -$0.09448 | -258.4% |
2009 | $0.05964 |